nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Foetal death—Methotrexate—germ cell cancer	0.0502	0.059	CcSEcCtD
Nalbuphine—OPRM1—telencephalic ventricle—germ cell cancer	0.0285	0.192	CbGeAlD
Nalbuphine—Speech impairment NOS—Methotrexate—germ cell cancer	0.0265	0.0312	CcSEcCtD
Nalbuphine—OPRD1—ganglion—germ cell cancer	0.026	0.175	CbGeAlD
Nalbuphine—Numbness—Vinblastine—germ cell cancer	0.0205	0.024	CcSEcCtD
Nalbuphine—Sensory loss—Vinblastine—germ cell cancer	0.0196	0.023	CcSEcCtD
Nalbuphine—OPRM1—ganglion—germ cell cancer	0.0177	0.119	CbGeAlD
Nalbuphine—Delusion—Ifosfamide—germ cell cancer	0.0173	0.0203	CcSEcCtD
Nalbuphine—Wheezing—Bleomycin—germ cell cancer	0.0139	0.0163	CcSEcCtD
Nalbuphine—Tingling sensation—Etoposide—germ cell cancer	0.012	0.0141	CcSEcCtD
Nalbuphine—Numbness—Etoposide—germ cell cancer	0.0117	0.0137	CcSEcCtD
Nalbuphine—Sensory loss—Etoposide—germ cell cancer	0.0112	0.0131	CcSEcCtD
Nalbuphine—Pulmonary oedema—Ifosfamide—germ cell cancer	0.0109	0.0128	CcSEcCtD
Nalbuphine—Wheezing—Cisplatin—germ cell cancer	0.0103	0.012	CcSEcCtD
Nalbuphine—Swelling—Ifosfamide—germ cell cancer	0.0101	0.0118	CcSEcCtD
Nalbuphine—OPRD1—telencephalon—germ cell cancer	0.01	0.0675	CbGeAlD
Nalbuphine—Depression—Vinblastine—germ cell cancer	0.00946	0.0111	CcSEcCtD
Nalbuphine—Bronchospasm—Bleomycin—germ cell cancer	0.00884	0.0104	CcSEcCtD
Nalbuphine—Hypoaesthesia—Vinblastine—germ cell cancer	0.00847	0.00995	CcSEcCtD
Nalbuphine—Cardiac arrest—Ifosfamide—germ cell cancer	0.00845	0.00993	CcSEcCtD
Nalbuphine—Swelling—Etoposide—germ cell cancer	0.00796	0.00935	CcSEcCtD
Nalbuphine—OPRM1—brainstem—germ cell cancer	0.0077	0.0518	CbGeAlD
Nalbuphine—Bronchospasm—Ifosfamide—germ cell cancer	0.00756	0.00887	CcSEcCtD
Nalbuphine—Hypoaesthesia—Bleomycin—germ cell cancer	0.00716	0.00841	CcSEcCtD
Nalbuphine—Pollakiuria—Ifosfamide—germ cell cancer	0.0071	0.00833	CcSEcCtD
Nalbuphine—Cramp muscle—Cisplatin—germ cell cancer	0.0069	0.0081	CcSEcCtD
Nalbuphine—OPRM1—telencephalon—germ cell cancer	0.00684	0.046	CbGeAlD
Nalbuphine—Speech disorder—Methotrexate—germ cell cancer	0.00673	0.00791	CcSEcCtD
Nalbuphine—Flushing—Bleomycin—germ cell cancer	0.00668	0.00784	CcSEcCtD
Nalbuphine—Cardiac arrest—Etoposide—germ cell cancer	0.00667	0.00784	CcSEcCtD
Nalbuphine—Vertigo—Vinblastine—germ cell cancer	0.00666	0.00782	CcSEcCtD
Nalbuphine—Sweating increased—Cisplatin—germ cell cancer	0.00645	0.00758	CcSEcCtD
Nalbuphine—Convulsion—Vinblastine—germ cell cancer	0.00642	0.00755	CcSEcCtD
Nalbuphine—Hypertension—Vinblastine—germ cell cancer	0.0064	0.00752	CcSEcCtD
Nalbuphine—Cramp muscle—Etoposide—germ cell cancer	0.00632	0.00742	CcSEcCtD
Nalbuphine—Erythema—Bleomycin—germ cell cancer	0.00626	0.00736	CcSEcCtD
Nalbuphine—Bradycardia—Ifosfamide—germ cell cancer	0.00626	0.00735	CcSEcCtD
Nalbuphine—OPRD1—head—germ cell cancer	0.00624	0.042	CbGeAlD
Nalbuphine—Flushing—Dactinomycin—germ cell cancer	0.00623	0.00731	CcSEcCtD
Nalbuphine—Hallucination—Ifosfamide—germ cell cancer	0.00612	0.00719	CcSEcCtD
Nalbuphine—OPRK1—head—germ cell cancer	0.00598	0.0403	CbGeAlD
Nalbuphine—Bronchospasm—Etoposide—germ cell cancer	0.00597	0.00701	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—germ cell cancer	0.00591	0.00694	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—germ cell cancer	0.00584	0.00686	CcSEcCtD
Nalbuphine—Flushing—Ifosfamide—germ cell cancer	0.00571	0.0067	CcSEcCtD
Nalbuphine—Paraesthesia—Vinblastine—germ cell cancer	0.00543	0.00638	CcSEcCtD
Nalbuphine—Bradycardia—Cisplatin—germ cell cancer	0.0054	0.00634	CcSEcCtD
Nalbuphine—Erythema—Ifosfamide—germ cell cancer	0.00535	0.00629	CcSEcCtD
Nalbuphine—OPRK1—cerebellum—germ cell cancer	0.00534	0.0359	CbGeAlD
Nalbuphine—Pulmonary oedema—Methotrexate—germ cell cancer	0.00516	0.00606	CcSEcCtD
Nalbuphine—Confusional state—Bleomycin—germ cell cancer	0.00515	0.00605	CcSEcCtD
Nalbuphine—Oedema—Bleomycin—germ cell cancer	0.00511	0.006	CcSEcCtD
Nalbuphine—Vision blurred—Ifosfamide—germ cell cancer	0.00504	0.00592	CcSEcCtD
Nalbuphine—Feeling abnormal—Vinblastine—germ cell cancer	0.00499	0.00586	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00495	0.00581	CcSEcCtD
Nalbuphine—Flushing—Cisplatin—germ cell cancer	0.00492	0.00578	CcSEcCtD
Nalbuphine—Agitation—Ifosfamide—germ cell cancer	0.00492	0.00578	CcSEcCtD
Nalbuphine—OPRM1—midbrain—germ cell cancer	0.00491	0.033	CbGeAlD
Nalbuphine—Hypoaesthesia—Etoposide—germ cell cancer	0.00483	0.00567	CcSEcCtD
Nalbuphine—Vertigo—Ifosfamide—germ cell cancer	0.00481	0.00565	CcSEcCtD
Nalbuphine—OPRM1—spinal cord—germ cell cancer	0.00479	0.0322	CbGeAlD
Nalbuphine—Abdominal pain—Vinblastine—germ cell cancer	0.00478	0.00562	CcSEcCtD
Nalbuphine—Hypotension—Bleomycin—germ cell cancer	0.00478	0.00561	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—germ cell cancer	0.00477	0.0056	CcSEcCtD
Nalbuphine—Convulsion—Ifosfamide—germ cell cancer	0.00464	0.00545	CcSEcCtD
Nalbuphine—Hypertension—Ifosfamide—germ cell cancer	0.00462	0.00543	CcSEcCtD
Nalbuphine—Erythema—Cisplatin—germ cell cancer	0.00461	0.00542	CcSEcCtD
Nalbuphine—Paraesthesia—Bleomycin—germ cell cancer	0.00459	0.00539	CcSEcCtD
Nalbuphine—Dyspnoea—Bleomycin—germ cell cancer	0.00456	0.00535	CcSEcCtD
Nalbuphine—OPRD1—brain—germ cell cancer	0.00452	0.0304	CbGeAlD
Nalbuphine—Flushing—Etoposide—germ cell cancer	0.00451	0.00529	CcSEcCtD
Nalbuphine—Hypersensitivity—Vinblastine—germ cell cancer	0.00446	0.00524	CcSEcCtD
Nalbuphine—Muscle spasms—Cisplatin—germ cell cancer	0.00444	0.00521	CcSEcCtD
Nalbuphine—Confusional state—Ifosfamide—germ cell cancer	0.0044	0.00517	CcSEcCtD
Nalbuphine—Oedema—Ifosfamide—germ cell cancer	0.00437	0.00513	CcSEcCtD
Nalbuphine—Vision blurred—Cisplatin—germ cell cancer	0.00435	0.00511	CcSEcCtD
Nalbuphine—Asthenia—Vinblastine—germ cell cancer	0.00434	0.0051	CcSEcCtD
Nalbuphine—OPRK1—brain—germ cell cancer	0.00434	0.0292	CbGeAlD
Nalbuphine—Tremor—Cisplatin—germ cell cancer	0.00432	0.00508	CcSEcCtD
Nalbuphine—OPRM1—endocrine gland—germ cell cancer	0.00431	0.029	CbGeAlD
Nalbuphine—OPRM1—head—germ cell cancer	0.00426	0.0286	CbGeAlD
Nalbuphine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00422	0.00496	CcSEcCtD
Nalbuphine—Feeling abnormal—Bleomycin—germ cell cancer	0.00421	0.00495	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—germ cell cancer	0.00414	0.00486	CcSEcCtD
Nalbuphine—OPRM1—testis—germ cell cancer	0.00411	0.0277	CbGeAlD
Nalbuphine—Hypotension—Ifosfamide—germ cell cancer	0.00408	0.00479	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—germ cell cancer	0.00406	0.00477	CcSEcCtD
Nalbuphine—Urticaria—Bleomycin—germ cell cancer	0.00406	0.00477	CcSEcCtD
Nalbuphine—Body temperature increased—Bleomycin—germ cell cancer	0.00404	0.00475	CcSEcCtD
Nalbuphine—Dizziness—Vinblastine—germ cell cancer	0.004	0.0047	CcSEcCtD
Nalbuphine—Convulsion—Cisplatin—germ cell cancer	0.004	0.0047	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00393	0.00461	CcSEcCtD
Nalbuphine—Paraesthesia—Ifosfamide—germ cell cancer	0.00392	0.00461	CcSEcCtD
Nalbuphine—Anxiety—Cisplatin—germ cell cancer	0.00391	0.0046	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.0039	0.00458	CcSEcCtD
Nalbuphine—Dyspnoea—Ifosfamide—germ cell cancer	0.00389	0.00457	CcSEcCtD
Nalbuphine—Somnolence—Ifosfamide—germ cell cancer	0.00388	0.00456	CcSEcCtD
Nalbuphine—Vomiting—Vinblastine—germ cell cancer	0.00385	0.00452	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—germ cell cancer	0.0038	0.00446	CcSEcCtD
Nalbuphine—Headache—Vinblastine—germ cell cancer	0.00379	0.00445	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—germ cell cancer	0.00377	0.00443	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—germ cell cancer	0.00377	0.00443	CcSEcCtD
Nalbuphine—Oedema—Cisplatin—germ cell cancer	0.00377	0.00442	CcSEcCtD
Nalbuphine—Hypersensitivity—Bleomycin—germ cell cancer	0.00377	0.00442	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—germ cell cancer	0.00372	0.00436	CcSEcCtD
Nalbuphine—Tachycardia—Cisplatin—germ cell cancer	0.00368	0.00432	CcSEcCtD
Nalbuphine—Asthenia—Bleomycin—germ cell cancer	0.00367	0.00431	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—germ cell cancer	0.00366	0.0043	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—germ cell cancer	0.00365	0.00429	CcSEcCtD
Nalbuphine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00364	0.00428	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—germ cell cancer	0.00363	0.00427	CcSEcCtD
Nalbuphine—Pruritus—Bleomycin—germ cell cancer	0.00362	0.00425	CcSEcCtD
Nalbuphine—Feeling abnormal—Ifosfamide—germ cell cancer	0.0036	0.00423	CcSEcCtD
Nalbuphine—Nausea—Vinblastine—germ cell cancer	0.00359	0.00422	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00357	0.0042	CcSEcCtD
Nalbuphine—Hypotension—Cisplatin—germ cell cancer	0.00352	0.00413	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00351	0.00412	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—germ cell cancer	0.00348	0.00409	CcSEcCtD
Nalbuphine—Urticaria—Ifosfamide—germ cell cancer	0.00347	0.00408	CcSEcCtD
Nalbuphine—Body temperature increased—Ifosfamide—germ cell cancer	0.00345	0.00406	CcSEcCtD
Nalbuphine—Abdominal pain—Ifosfamide—germ cell cancer	0.00345	0.00406	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—germ cell cancer	0.00342	0.00402	CcSEcCtD
Nalbuphine—Paraesthesia—Cisplatin—germ cell cancer	0.00338	0.00397	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—germ cell cancer	0.00337	0.00395	CcSEcCtD
Nalbuphine—Dyspnoea—Cisplatin—germ cell cancer	0.00336	0.00394	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—germ cell cancer	0.00334	0.00392	CcSEcCtD
Nalbuphine—Vomiting—Bleomycin—germ cell cancer	0.00325	0.00382	CcSEcCtD
Nalbuphine—Depression—Methotrexate—germ cell cancer	0.00323	0.00379	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—germ cell cancer	0.00322	0.00379	CcSEcCtD
Nalbuphine—Rash—Bleomycin—germ cell cancer	0.00322	0.00379	CcSEcCtD
Nalbuphine—Dermatitis—Bleomycin—germ cell cancer	0.00322	0.00378	CcSEcCtD
Nalbuphine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00322	0.00378	CcSEcCtD
Nalbuphine—Asthenia—Ifosfamide—germ cell cancer	0.00313	0.00368	CcSEcCtD
Nalbuphine—Feeling abnormal—Cisplatin—germ cell cancer	0.0031	0.00364	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—germ cell cancer	0.0031	0.00364	CcSEcCtD
Nalbuphine—Pruritus—Ifosfamide—germ cell cancer	0.00309	0.00363	CcSEcCtD
Nalbuphine—OPRM1—brain—germ cell cancer	0.00309	0.0208	CbGeAlD
Nalbuphine—Dyspnoea—Etoposide—germ cell cancer	0.00308	0.00361	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—germ cell cancer	0.00307	0.0036	CcSEcCtD
Nalbuphine—Nausea—Bleomycin—germ cell cancer	0.00304	0.00357	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—germ cell cancer	0.00303	0.00356	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—germ cell cancer	0.00301	0.00353	CcSEcCtD
Nalbuphine—Body temperature increased—Cisplatin—germ cell cancer	0.00298	0.0035	CcSEcCtD
Nalbuphine—Dizziness—Ifosfamide—germ cell cancer	0.00289	0.00339	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—germ cell cancer	0.00284	0.00334	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—germ cell cancer	0.00283	0.00333	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00282	0.00331	CcSEcCtD
Nalbuphine—Vomiting—Ifosfamide—germ cell cancer	0.00278	0.00326	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—germ cell cancer	0.00277	0.00326	CcSEcCtD
Nalbuphine—Rash—Ifosfamide—germ cell cancer	0.00275	0.00323	CcSEcCtD
Nalbuphine—Dermatitis—Ifosfamide—germ cell cancer	0.00275	0.00323	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—germ cell cancer	0.00274	0.00322	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—germ cell cancer	0.00273	0.0032	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—germ cell cancer	0.00273	0.0032	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—germ cell cancer	0.0027	0.00317	CcSEcCtD
Nalbuphine—Nausea—Ifosfamide—germ cell cancer	0.00259	0.00305	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—germ cell cancer	0.00254	0.00299	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—germ cell cancer	0.00253	0.00297	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—germ cell cancer	0.00248	0.00291	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—germ cell cancer	0.00248	0.00291	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—germ cell cancer	0.00244	0.00287	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—germ cell cancer	0.00239	0.00281	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—germ cell cancer	0.00239	0.0028	CcSEcCtD
Nalbuphine—Rash—Cisplatin—germ cell cancer	0.00237	0.00279	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—germ cell cancer	0.00237	0.00279	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—germ cell cancer	0.00228	0.00268	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—germ cell cancer	0.00227	0.00267	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—germ cell cancer	0.00224	0.00263	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—germ cell cancer	0.00219	0.00258	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—germ cell cancer	0.00219	0.00258	CcSEcCtD
Nalbuphine—Rash—Etoposide—germ cell cancer	0.00218	0.00255	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—germ cell cancer	0.00217	0.00255	CcSEcCtD
Nalbuphine—Headache—Etoposide—germ cell cancer	0.00216	0.00254	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—germ cell cancer	0.00208	0.00245	CcSEcCtD
Nalbuphine—Nausea—Etoposide—germ cell cancer	0.00205	0.00241	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—germ cell cancer	0.002	0.00235	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—germ cell cancer	0.00193	0.00227	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—germ cell cancer	0.00186	0.00218	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—germ cell cancer	0.00184	0.00216	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—germ cell cancer	0.00184	0.00216	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—germ cell cancer	0.00182	0.00214	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—germ cell cancer	0.0017	0.002	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00169	0.00198	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—germ cell cancer	0.00164	0.00193	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—germ cell cancer	0.00163	0.00192	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—germ cell cancer	0.00163	0.00192	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—germ cell cancer	0.00152	0.00179	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—germ cell cancer	0.00148	0.00174	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—germ cell cancer	0.00146	0.00172	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—germ cell cancer	0.00137	0.00161	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—germ cell cancer	0.00131	0.00154	CcSEcCtD
Nalbuphine—Rash—Methotrexate—germ cell cancer	0.0013	0.00153	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—germ cell cancer	0.0013	0.00153	CcSEcCtD
Nalbuphine—Headache—Methotrexate—germ cell cancer	0.00129	0.00152	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—germ cell cancer	0.00123	0.00144	CcSEcCtD
